In the real world, would Dana-Farber have submitte
Post# of 72440
"Hey everyone, here's my study that failed, publish it."
Of course not.
There are so many indications of possible success. I simply can't conceive of the idea that 3 drugs, for 4 (and soon to be 5) different indications, would ALL fail. Success for any one of those indications would put the share price far higher than it is now.